Gottlieb, A. B., Strober, B., Tha?i, D., Gordon, K., Kundu, S., Kisa, R., Wei, L., Banerjee, S., & Merola, J. (2020). BMS-986165, an Oral, Selective TYK2 Inhibitor, in the Treatment of Moderate to Severe Psoriasis as Assessed by the Static Physician’s Global Assessment (sPGA)/Body Surface Area (BSA) Composite Tool (sPGAxBSA), a Clinically Useful Alternative to PASI. SKIN The Journal of Cutaneous Medicine, 4(5), s29.